SOX2 and endometrial cancer: After overexpressing PVT1 in endometrial cancer non-stem cells and ECSCs, the expression of Sox2 was significantly decreased as noted in the qRT-PCR analysis, while the expression of Sox2 increased after PVT1 knockdown (Figure S3B).